N¹-(7-Chloro-quinolin-4-yl)-dodecane-1,12-diamine | 1026678-59-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N¹-(7-Chloro-quinolin-4-yl)-dodecane-1,12-diamine
• 英文别名: N'-(7-chloroquinolin-4-yl)dodecane-1,12-diamine
• CAS: 1026678-59-0
• 化学式: C₂₁H₃₂ClN₃
• 分子量: 361.958
• InChiKey: JGNGALFRHHMDPE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  25
• 可旋转键数：
  13
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  50.9
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl 2-chloro-4-methyl-6-phenylpyrimidine-5-carboxylate 、 N¹-(7-Chloro-quinolin-4-yl)-dodecane-1,12-diamine 在 potassium carbonate 作用下， 以 四氢呋喃 为溶剂， 反应 48.0h， 以65%的产率得到5-ethoxycarbonyl-6-methyl-4-phenyl-2-[12-(7-chloroquinolin-4-ylamino)dodecylamino]pyrimidine
  参考文献：
  名称：

  2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure–activity relationship and mode of action studies

  摘要：

  2-Aminopyrimidine based 4-aminoquinolines were synthesized using an efficacious protocol. Some of the compounds showed in vitro anti-plasmodial activity against drug-sensitive CQ(S) (3D7) and drug-resistant CQ(R) (K1) strains of Plasmodium falciparum in the nM range. In particular, 5-isopropyloxycarbonyl-6-methyl-4-(2-nitrophenyl)-2-[(7-chloroquinolin-4-ylamino)butylamino] pyrimidine depicted the lowest IC50 (3.6 nM) value (56-fold less than CQ) against CQ(R) strain. Structure activity profile and binding with heme, mu-oxo-heme have been studied. Binding assays with DNA revealed better binding with target parasite type AT rich pUC18 DNA. Most compounds were somewhat cytotoxic, but especially cytostatic. Molecular docking analysis with Pf DHFR allowed identification of stabilizing interactions. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.03.007
• 作为产物：
  描述：

  7-氯-4-羟基喹啉 在 三氯氧磷 作用下， 反应 4.0h， 生成 N¹-(7-Chloro-quinolin-4-yl)-dodecane-1,12-diamine
  参考文献：
  名称：

  抗疟药：合成4-氨基喹啉类药物，可在疟疾寄生虫中规避耐药性†

  摘要：

  此处描述的策略已允许合成一系列4-氨基喹啉抗疟药。对先前合成方法的实质性改进包括用纯胺而不是苯酚进行亲核取代，区域选择性还原烷基化以将二氨基烷烃侧链上的末端伯胺（12a-20a）转化为二乙氨基，以及通过使用碱性氧化铝的柱色谱法进行纯化。用硼氘化钠（与硼氢化钠相比）进行区域选择性还原烷基化后获得的1 H nmr光谱表明，该还原烷基化是通过形成并随后原位还原相应的二酰胺而进行的。

  DOI：

  10.1002/jhet.5570340149

文献信息

• Quinoline–Pyrimidine Hybrids: Synthesis, Antiplasmodial Activity, SAR, and Mode of Action Studies
  作者：Kamaljit Singh、Hardeep Kaur、Peter Smith、Carmen de Kock、Kelly Chibale、Jan Balzarini

  DOI：10.1021/jm4014778

  日期：2014.1.23

  For the treatment of malaria which affects nearly 200 million people each year and the continued exacerbation by the emergence of drug resistance to most of the available antimalarials, the "covalent bitherapy" suggests hybrid molecules to be the next-generation antimalarial drugs. In this investigation, new hybrids of 4-aminoquinoline and pyrimidine moieties that show antiplasmodial activity in the nM range against chloroquine-resistant as well as chloroquine-sensitive strains of Plasmodium falciparum have been prepared. Cytotoxicity evaluation and mode of action of most potent hybrid molecule have been conducted.
• Antimalarials: Synthesis of 4-aminoquinolines that circumvent drug resistance in malaria parasites
  作者：Dibyendu De、Larry D. Byers、Donald J. Krogstad

  DOI：10.1002/jhet.5570340149

  日期：1997.1

  substitution with neat amine rather than in phenol, regioselective reductive alkylation to convert the terminal primary amine (12a–20a) on the diaminoalkane side chain to a diethylamino group, and purification by column chromatography with basic alumina. The 1H nmr spectra obtained after regioselective reductive alkylation with sodium borodeuteride (in comparison with sodium borohydride) demonstrated that

  此处描述的策略已允许合成一系列4-氨基喹啉抗疟药。对先前合成方法的实质性改进包括用纯胺而不是苯酚进行亲核取代，区域选择性还原烷基化以将二氨基烷烃侧链上的末端伯胺（12a-20a）转化为二乙氨基，以及通过使用碱性氧化铝的柱色谱法进行纯化。用硼氘化钠（与硼氢化钠相比）进行区域选择性还原烷基化后获得的1 H nmr光谱表明，该还原烷基化是通过形成并随后原位还原相应的二酰胺而进行的。
• 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure–activity relationship and mode of action studies
  作者：Kamaljit Singh、Hardeep Kaur、Kelly Chibale、Jan Balzarini、Susan Little、Prasad V. Bharatam

  DOI：10.1016/j.ejmech.2012.03.007

  日期：2012.6

  2-Aminopyrimidine based 4-aminoquinolines were synthesized using an efficacious protocol. Some of the compounds showed in vitro anti-plasmodial activity against drug-sensitive CQ(S) (3D7) and drug-resistant CQ(R) (K1) strains of Plasmodium falciparum in the nM range. In particular, 5-isopropyloxycarbonyl-6-methyl-4-(2-nitrophenyl)-2-[(7-chloroquinolin-4-ylamino)butylamino] pyrimidine depicted the lowest IC50 (3.6 nM) value (56-fold less than CQ) against CQ(R) strain. Structure activity profile and binding with heme, mu-oxo-heme have been studied. Binding assays with DNA revealed better binding with target parasite type AT rich pUC18 DNA. Most compounds were somewhat cytotoxic, but especially cytostatic. Molecular docking analysis with Pf DHFR allowed identification of stabilizing interactions. (C) 2012 Elsevier Masson SAS. All rights reserved.